Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

This program funds the creation of AI-driven predictive biomarkers for chronic non-communicable diseases, enabling clinicians and researchers to assess disease progression and treatment response more accurately. It supports development of trustworthy AI tools and clinically validated biomarkers to improve personalised medicine, clinical research and health outcomes.